AMP Amphion Innovations Plc

RNS Number:6598L
Amphion Innovations PLC
07 November 2006


                              Amphion Innovations

      Partner Company Durham Scientific Crystals Closes #875,000 Financing


London, UK - 7 November 2006 - Amphion Innovations plc today announces that its
Partner Company, Durham Scientific Crystals Ltd. (DSC), a Durham University
spin-out developing state-of-the-art semiconductor materials for the medical
imaging and security imaging markets, has raised an initial #875,000 at #2 per
share for the first close of a larger Series F financing. Amphion now owns 26.3%
of Durham Scientific Crystals which is now valued at #8.3m post money.


DSC has developed a breakthrough technology that is significant in the
transition from analogue to digital x-ray imaging. The Company has
commercialised the use of materials based on cadmium telluride, the premier
choice for use as digital detectors of x-rays and gamma rays, and will allow for
significantly improved imaging in markets such as airport security and medical
imaging.


Cadmium telluride materials are currently too expensive and too difficult to
produce to be used in large scale commercial applications. DSC, however, has
developed a breakthrough production method to produce these crystals from a
vapour phase, rather than the conventional liquid based techniques, enabling the
crystals to be produced at an attractive cost and quality enabling their large
scale commercial use in the future.


The transformation to digital x-ray scanners in security imaging will be a
significant improvement as the technology will allow much faster screening and
direct 'fingerprinting' of dangerous materials such as liquid bombs and plastic
explosive, which are currently hard to distinguish from other plastics.


In medical imaging, cadmium telluride will offer significant advantages over the
current materials including greater sensitivity to x-rays to enable faster
imaging and lower dosing, and will increase the ability to understand diseases,
such as Alzheimer's and Cancer, and detect them in their early stages,



The capital raised in this latest round of financing will support continued
research and development, staffing and overhead expenses.  DSC is also working
with non-commercial partners to optimise its crystals with electrode technology
that makes it easier to integrate them into the electronic infrastructure of
scanners.



Richard C.E. Morgan, Chief Executive Officer of Amphion, said:



"Due to the recent security issues in our airports, and the continued desire to
diagnose and treat diseases earlier, there is a large growing need for faster,
more effective and clearer digital imaging. We believe that DSC has the
technology to meet these needs and this financing signifies that our investors
and partners see DSC as a company poised for tremendous growth and value the
technology and recognise its prospects."



Dr Arnab Basu, Chief Executive Officer of Durham Scientific Crystals, said:



"We are excited by the response of the investment community and these funds will
allow us to accelerate our R&D as we further continue to commercialise our
products to significantly improve imaging in the security and medical markets."



For further information please contact:


Amphion Innovations plc
Josh Berkman, Media Relations                         +1 (646) 747-7158


Financial Dynamics                                    +44 207 269 7169
Ben Atwell
John Gilbert



About Amphion Innovations plc



Amphion Innovations plc is listed on the AIM Exchange in London under the symbol
AMP. Amphion's business is the formation, financing, management and development
of life sciences and technology companies, working in partnership with
corporations, governments, universities and entrepreneurs seeking to
commercialize their intellectual property.



Durham Scientific Crystals, Ltd.



Durham Scientific Crystals, Ltd. is a research and development company, which
was spun-out from the Physics Department of the University of Durham.  The
company was formed in April 2003 and has been actively involved in the research
and development of semiconductor materials, in conjunction with the University
research labs.  DSC's technological expertise is a result of over three decades
of semiconductor research at the University of Durham.



DSC is located in Sedgefield, County Durham, England and is developing
next-generation proprietary products and processes based around key
semiconductor optoelectronic materials used in medical and security
applications.




                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

MSCUUGPPGUPQGUM

Amphion Innovations (LSE:AMP)
Gráfica de Acción Histórica
De Sep 2024 a Oct 2024

Amphion Innovations (LSE:AMP)
Gráfica de Acción Histórica
De Oct 2023 a Oct 2024